VWR Corporation (NASDAQ:VWR) was downgraded by investment analysts at BidaskClub from a “sell” rating to a “strong sell” rating in a research note issued on Thursday, July 27th.
Several other equities research analysts have also commented on VWR. Zacks Investment Research upgraded shares of VWR Corporation from a “hold” rating to a “buy” rating and set a $37.00 price target on the stock in a research note on Tuesday, June 6th. TheStreet upgraded shares of VWR Corporation from a “c” rating to a “b-” rating in a research note on Wednesday, April 19th. Finally, William Blair lowered shares of VWR Corporation from an “outperform” rating to a “market perform” rating in a research note on Friday, May 5th. Three equities research analysts have rated the stock with a sell rating, three have given a hold rating and two have issued a buy rating to the stock. The company has a consensus rating of “Hold” and a consensus target price of $30.50.
VWR Corporation (NASDAQ VWR) opened at 32.98 on Thursday. The firm has a market capitalization of $4.35 billion, a price-to-earnings ratio of 30.54 and a beta of 1.19. VWR Corporation has a one year low of $24.42 and a one year high of $37.25. The stock has a 50 day moving average price of $33.00 and a 200-day moving average price of $29.90.
VWR Corporation (NASDAQ:VWR) last issued its earnings results on Monday, July 31st. The medical research company reported $0.49 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.45 by $0.04. VWR Corporation had a net margin of 3.12% and a return on equity of 15.54%. The firm had revenue of $1.18 billion for the quarter, compared to analysts’ expectations of $1.16 billion. During the same quarter last year, the company posted $0.42 earnings per share. VWR Corporation’s revenue was up 2.2% on a year-over-year basis. On average, analysts predict that VWR Corporation will post $1.85 earnings per share for the current fiscal year.
ILLEGAL ACTIVITY NOTICE: “VWR Corporation (NASDAQ:VWR) Downgraded by BidaskClub to “Strong Sell”” was published by BBNS and is the sole property of of BBNS. If you are accessing this piece on another publication, it was stolen and republished in violation of international copyright and trademark legislation. The correct version of this piece can be accessed at https://baseballnewssource.com/markets/vwr-corporation-nasdaqvwr-lowered-to-strong-sell-at-bidaskclub-updated/1309020.html.
A number of institutional investors have recently bought and sold shares of the company. FNY Managed Accounts LLC purchased a new position in VWR Corporation during the first quarter worth approximately $100,000. First Mercantile Trust Co. raised its stake in shares of VWR Corporation by 195.2% in the first quarter. First Mercantile Trust Co. now owns 6,200 shares of the medical research company’s stock worth $175,000 after buying an additional 4,100 shares during the period. Teacher Retirement System of Texas bought a new stake in shares of VWR Corporation during the first quarter worth about $205,000. Neuberger Berman Group LLC bought a new stake in shares of VWR Corporation during the first quarter worth about $219,000. Finally, PNC Financial Services Group Inc. raised its stake in shares of VWR Corporation by 954.2% in the first quarter. PNC Financial Services Group Inc. now owns 8,455 shares of the medical research company’s stock worth $238,000 after buying an additional 7,653 shares during the period.
About VWR Corporation
VWR Corporation is a provider of product and service solutions to laboratory and production customers. The Company offers a portfolio of branded and private label laboratory products, services and solutions to the life science, general research and applied markets. The Company operates in two segments: Americas and EMEA-APAC.
Receive News & Ratings for VWR Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VWR Corporation and related companies with our FREE daily email newsletter.